Diffusion-weighted magnetic resonance imaging combined with neutrophil-to-lymphocyte ratio predicts pathological response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
AME Medical Journal · 2026-06 · 11 · 14-14
DOI: 10.21037/amj-25-44 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Medical Journal, 2026-06. Verfasst von Daxuan Hao und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hao, D., Yang, Y., Li, X., Wu, X., Chen, Y., & Wang, J. (2026). Diffusion-weighted magnetic resonance imaging combined with neutrophil-to-lymphocyte ratio predicts pathological response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. AME Medical Journal, 11, 14-14. https://doi.org/10.21037/amj-25-44
Vancouver
Hao D, Yang Y, Li X, Wu X, Chen Y, Wang J. Diffusion-weighted magnetic resonance imaging combined with neutrophil-to-lymphocyte ratio predicts pathological response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. AME Medical Journal. 2026;11:14-14. doi:10.21037/amj-25-44
BibTeX
@article{Hao2026,
author = {Hao, Daxuan and Yang, Yuanyuan and Li, Xue and Wu, Xiaoyuan and Chen, Yongshun and Wang, Jianhua},
title = {Diffusion-weighted magnetic resonance imaging combined with neutrophil-to-lymphocyte ratio predicts pathological response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma},
journal = {AME Medical Journal},
year = {2026},
volume = {11},
pages = {14--14},
doi = {10.21037/amj-25-44}
}
EUVIMED